Most recently, Crossbow Therapeutics raised $30.3M in its Early Stage VC (Sep 2025).
- ·The complete investor list: 13 names
- ·Watch Crossbow Therapeutics: the Monday email on marks, rounds and moves
Crossbow Therapeutics round by round
2 roundsHow much has Crossbow Therapeutics raised?
Crossbow Therapeutics has raised $198 million in total; 2 of its rounds are on record. The largest on record was a $37.6 million early-stage round in Mar 2023; the most recent was a $30.3 million early-stage round in Sep 2025.
Crossbow Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Sep 2025 ($30.3 million sold to 17 investors).
Crossbow Therapeutics investors
13 investors are on record for Crossbow Therapeutics, including Mirae Asset Capital, Arkin Capital, Pfizer Ventures and Eli Lilly and Company Foundation. The early-stage round in Sep 2025 drew 17 investors.
13 investors have backed Crossbow Therapeutics.
Frequently asked about Crossbow Therapeutics
- How much has Crossbow Therapeutics raised?
- Crossbow Therapeutics has raised $198.3M in total across 2 recorded funding rounds.
- When was Crossbow Therapeutics's last funding round?
- Crossbow Therapeutics's most recent recorded round was Early Stage VC in Sep 2025, raising $30.3M.